Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumors

Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumors

Bibliographic Details
Main Authors: Isambert, Nicolas, Fumoleau, Pierre, Paul, Catherine, Ferrand, Christophe, Zanetta, Sylvie, Bauer, Jacques, Ragot, Kevin, Lizard, Gérard, Jeannin, Jean-François, Bardou, Marc
Format: Online
Language:English
Published: BioMed Central 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626800/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626800/

Similar Items